Interpharm Holdings Valuation
| IPAH Stock | USD 0 0.00 0.00% |
Interpharm Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Interpharm Holdings from evaluating the firm fundamentals such as Return On Asset of -0.19, current valuation of 2.07 M, and Return On Equity of -1.17 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Interpharm Holdings' valuation include:
Overvalued
Today
Please note that Interpharm Holdings' price fluctuation is very steady at this time. Calculation of the real value of Interpharm Holdings is based on 3 months time horizon. Increasing Interpharm Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Interpharm Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Interpharm Stock. However, Interpharm Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0041 | Real 0.003444 | Hype 0.0041 |
The intrinsic value of Interpharm Holdings' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Interpharm Holdings' stock price.
Estimating the potential upside or downside of Interpharm Holdings helps investors to forecast how Interpharm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Interpharm Holdings more accurately as focusing exclusively on Interpharm Holdings' fundamentals will not take into account other important factors: When choosing an evaluation method for Interpharm Holdings, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Interpharm Holdings Cash |
|
About Interpharm Holdings Valuation
An absolute valuation paradigm, as applied to Interpharm Stock, attempts to find the value of Interpharm Holdings based on its fundamental and basic technical indicators. By analyzing Interpharm Holdings's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Interpharm Holdings's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Interpharm Holdings. We calculate exposure to Interpharm Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Interpharm Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 24.9 M | 26.2 M | |
| Pretax Profit Margin | (0.21) | (0.20) | |
| Operating Profit Margin | (0.14) | (0.16) | |
| Net Loss | (0.21) | (0.20) | |
| Gross Profit Margin | 0.26 | 0.27 |
Interpharm Holdings Current Valuation Indicators
Valuation refers to the process of determining the present value of Interpharm Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Interpharm we look at many different elements of the entity such as Interpharm's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Interpharm Holdings, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Interpharm Holdings' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Interpharm Holdings' worth.Complementary Tools for Interpharm Stock analysis
When running Interpharm Holdings' price analysis, check to measure Interpharm Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpharm Holdings is operating at the current time. Most of Interpharm Holdings' value examination focuses on studying past and present price action to predict the probability of Interpharm Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Interpharm Holdings' price. Additionally, you may evaluate how the addition of Interpharm Holdings to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |